GNTA logo

GNTAGenenta Science SpA - ADR

$1.69
$0.05
(3.13%)
Today
Closed $1.65
$0.04
(2.42%)
After Hours
Updated: 06:25 PM EDT
Mkt Cap$37.49M
Vol501,493.00
News
all
press releases
News Placeholder
Genenta Stock Rises Pre-Market After Cell Therapy Improves Survival In Certain Tumor Patients
The company said that 25 patients have been treated with Temferon as of November 21, and 44% of glioblastoma multiforme patients have reached 18-month survival.
Stocktwits
News Placeholder
GNTA Stock Skyrockets 300% Pre-Market Toward Record Highs: What’s Driving The Super Rally?
Stocktwits
<
...
1
>

Advertisement|Remove ads.